Literature DB >> 10643657

Formation of modified cleavage termini from the reaction of chromium(V) with DNA.

K D Sugden1.   

Abstract

Reaction of a 25 bp oligonucleotide with the high valent chromium complex, bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (Cr(V)-EHBA) produced both Frank- and alkali-labile strand breaks that were sequence-neutral. Frank strand break formation was found to be O2-dependent while formation of alkali-labile strand breaks were O2-independent. Reaction of Cr(V)-EHBA with the 5'-32P-labeled oligomer under oxygenated conditions formed the modified 3'-terminus, 3'-phosphoglycolate, as well as the 3'-phosphate terminus. Formation of the 3'-phosphoglycolate termini, and the O2 dependence of the reactions were consistent with a mechanism involving abstraction of the C4' hydrogen atom from the deoxyribose moiety of DNA. Identical reactions using the 3'-32P-labeled oligomer yielded only 5'-phosphate termini as assigned by co-migration with Maxam-Gilbert markers. Analogous cleavage profiles and modified termini were observed for the reaction of Cr(V)-EHBA and DNA in the presence of hydrogen peroxide. With the addition of hydrogen peroxide, the DNA cleavage reactions were O2-independent and the level of DNA cleavage was enhanced over that observed with Cr(V)-EHBA alone. These findings suggest an oxidation mechanism whereby a reductive intermediate of the carcinogen chromate, Cr(V), can cause DNA damage that mimics oxygen radical DNA damaging pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10643657     DOI: 10.1016/s0162-0134(99)00189-0

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  9 in total

Review 1.  A review of heavy metal cation binding to deoxyribonucleic acids for the creation of chemical sensors.

Authors:  Vangelis George Kanellis; Cristobal G Dos Remedios
Journal:  Biophys Rev       Date:  2018-09-18

2.  The intracellular redox stress caused by hexavalent chromium is selective for proteins that have key roles in cell survival and thiol redox control.

Authors:  Judith M Myers; William E Antholine; Charles R Myers
Journal:  Toxicology       Date:  2011-01-13       Impact factor: 4.221

3.  Non-enzymatic phosphorylation of bovine serum albumin by Cr(V) complexes: role in Cr(VI)-induced phosphorylation and toxicity.

Authors:  Chellappa Vasant; Sundararaj Sankaramanivel; Mahadevan Jana; Rama Rajaram; Thirumalachari Ramasami
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

4.  The pro-oxidant chromium(VI) inhibits mitochondrial complex I, complex II, and aconitase in the bronchial epithelium: EPR markers for Fe-S proteins.

Authors:  Charles R Myers; William E Antholine; Judith M Myers
Journal:  Free Radic Biol Med       Date:  2010-09-27       Impact factor: 7.376

Review 5.  The effects of chromium(VI) on the thioredoxin system: implications for redox regulation.

Authors:  Charles R Myers
Journal:  Free Radic Biol Med       Date:  2012-04-18       Impact factor: 7.376

6.  Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.

Authors:  G Quievryn; M Goulart; J Messer; A Zhitkovich
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

7.  The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells.

Authors:  Judith M Myers; Charles R Myers
Journal:  Free Radic Biol Med       Date:  2009-08-22       Impact factor: 7.376

8.  Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells.

Authors:  Judith M Myers; William E Antholine; Charles R Myers
Journal:  Toxicology       Date:  2008-02-02       Impact factor: 4.221

9.  Addition of DNA to Cr(VI) and cytochrome b5 containing proteoliposomes leads to generation of DNA strand breaks and Cr(III) complexes.

Authors:  Griselda R Borthiry; William E Antholine; Judith M Myers; Charles R Myers
Journal:  Chem Biodivers       Date:  2008-08       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.